These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 7331542)

  • 1. When is a shunt no longer necessary? An investigation of 300 patients with hydrocephalus and myelomeningocele: 11-22 year follow up.
    Lorber J; Pucholt V
    Z Kinderchir; 1981 Dec; 34(4):327-9. PubMed ID: 7331542
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Long-term results of hydrocephalus with myelomeningocele].
    Kojima N; Tamaki N; Matsumoto S
    No To Shinkei; 1990 Sep; 42(9):879-88. PubMed ID: 2245084
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rate of shunt revision as a function of age in patients with shunted hydrocephalus due to myelomeningocele.
    Dupepe EB; Hopson B; Johnston JM; Rozzelle CJ; Jerry Oakes W; Blount JP; Rocque BG
    Neurosurg Focus; 2016 Nov; 41(5):E6. PubMed ID: 27798984
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chronic headaches in adults with spina bifida and associated hydrocephalus.
    Edwards RJ; Witchell C; Pople IK
    Eur J Pediatr Surg; 2003 Dec; 13 Suppl 1():S13-7. PubMed ID: 14758561
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CSF shunt removal in children with hydrocephalus.
    Iannelli A; Rea G; Di Rocco C
    Acta Neurochir (Wien); 2005 May; 147(5):503-7; discussion 507. PubMed ID: 15838593
    [TBL] [Abstract][Full Text] [Related]  

  • 6. To shunt or not to shunt: hydrocephalus and dysraphism.
    Rekate HL
    Clin Neurosurg; 1985; 32():593-607. PubMed ID: 2415285
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Toward reducing shunt placement rates in patients with myelomeningocele.
    Chakraborty A; Crimmins D; Hayward R; Thompson D
    J Neurosurg Pediatr; 2008 May; 1(5):361-5. PubMed ID: 18447669
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Monte Carlo simulation of cerebrospinal fluid shunt failure and definition of instability among shunt-treated patients with hydrocephalus.
    Piatt JH; Cosgriff M
    J Neurosurg; 2007 Dec; 107(6 Suppl):474-8. PubMed ID: 18154016
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Progressive hydrocephalus in teenage spina bifida patients.
    Vaishnav A; MacKinnon AE
    Z Kinderchir; 1986 Dec; 41 Suppl 1():36-7. PubMed ID: 3544588
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CSF outflow resistance as predictor of shunt function. A long-term study.
    Malm J; Lundkvist B; Eklund A; Koskinen LO; Kristensen B
    Acta Neurol Scand; 2004 Sep; 110(3):154-60. PubMed ID: 15285771
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Myelomeningocele: long-term neurosurgical treatment and follow-up in 202 patients.
    Talamonti G; D'Aliberti G; Collice M
    J Neurosurg; 2007 Nov; 107(5 Suppl):368-86. PubMed ID: 18459900
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuroendoscopic treatment of multiloculated hydrocephalus in children.
    Spennato P; Cinalli G; Ruggiero C; Aliberti F; Trischitta V; Cianciulli E; Maggi G
    J Neurosurg; 2007 Jan; 106(1 Suppl):29-35. PubMed ID: 17233309
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multiple intestinal duplications in a child with thoracic myelomeningocele and hydrocephalus.
    Olsen L; Annerén G; Henze A; Lundkvist K; Lönnerholm T
    Eur J Pediatr Surg; 1992 Feb; 2(1):45-8. PubMed ID: 1571328
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Evaluation of shunt treatment in hydrocephalus with myelomeningocele: some factors relating to mental prognosis].
    Kojima N; Tamaki N; Matsumoto S
    No To Shinkei; 1988 Dec; 40(12):1181-7. PubMed ID: 3248195
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Pregnancy and delivery in women with cerebrospinal fluid shunt due to hydrocephalus].
    Nikolov A; Surchev Zh; Nalbanski B; Diavolov V; Dimitrov A
    Akush Ginekol (Sofiia); 2008; 47(2):3-10. PubMed ID: 18642578
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical evaluation and surveillance imaging of children with myelomeningocele and shunted hydrocephalus: a follow-up study.
    Wetzel JS; Heaner DP; Gabel BC; Tubbs RS; Chern JJ
    J Neurosurg Pediatr; 2019 Feb; 23(2):153-158. PubMed ID: 30497223
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevention of ventricular catheter obstruction and slit ventricle syndrome by the prophylactic use of the Integra antisiphon device in shunt therapy for pediatric hypertensive hydrocephalus: a 25-year follow-up study.
    Gruber RW; Roehrig B
    J Neurosurg Pediatr; 2010 Jan; 5(1):4-16. PubMed ID: 20043731
    [TBL] [Abstract][Full Text] [Related]  

  • 18. About the rate of shunt complications in patients with hydrocephalus and myelomeningocele.
    Rolle U; Gräfe G
    Eur J Pediatr Surg; 1999 Dec; 9 Suppl 1():51-2. PubMed ID: 10661803
    [No Abstract]   [Full Text] [Related]  

  • 19. [Clinical analysis of shunted hydrocephalic neonates and sucklings--observation on obstruction and infection of shunting system].
    Hayashi T; Hashimoto T; Fukuda S; Anegawa S; Torigoe R
    No To Shinkei; 1990 Nov; 42(11):1049-54. PubMed ID: 2076349
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preliminary experiences with the Orbis-Sigma-System as a ventriculo-peritoneal shunt.
    Kaiser G; Bittel M
    Eur J Pediatr Surg; 1992 Jun; 2(3):186-7. PubMed ID: 1498115
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.